Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

OBJECTIVES: To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients’ human immunodeficiency virus (HIV) co-infection status. METHODS: We conducted a retrospective cohort analysis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagwa, Evans L, Mantel-Teeuwisse, Aukje K, Ruswa, Nunurai C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219090/
https://www.ncbi.nlm.nih.gov/pubmed/25383192
http://dx.doi.org/10.1186/2052-3211-7-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219090/
https://www.ncbi.nlm.nih.gov/pubmed/25383192
http://dx.doi.org/10.1186/2052-3211-7-14

Ejemplares similares